✦ LIBER ✦

Safety and patient outcomes with lubiprostone for up to 52 weeks in patients with irritable bowel syndrome with constipation

✍ Scribed by W. D. Chey; D. A. Drossman; J. F. Johanson; C. Scott; R. M. Panas; R. Ueno

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical trial: lubiprostone in patients

✍ D. A. DROSSMAN; W. D. CHEY; J. F. JOHANSON; R. FASS; C. SCOTT; R. PANAS; R. UENO 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 477 KB

Relationship between symptoms and hypers

✍ S. D. KUIKEN; R. LINDEBOOM; G. N. TYTGAT; G. E. BOECKXSTAENS 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

Patients treated by tegaserod for irrita

✍ Tatiana Reitblat; Doron Zamir; Ilia Polishchuck; Galina Novochatko; Stephen Maln 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 93 KB

The effect of fluoxetine in patients wit

✍ H. VAHEDI; S. MERAT; A. RASHIDIOON; A. GHODDOOSI; R. MALEKZADEH 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

Pilot study of the efficacy of renzaprid

✍ J. TACK; S. J. MIDDLETON; M. C. HORNE; H. PIESSEVAUX; J. S. BLOOR; N. L. MEYERS; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB

The effects of withdrawing tegaserod tre

✍ K. D. Bardhan; A. Forbes; C. L. Marsden; T. Mason; G. Short 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 421 KB